Handelsbanken Fonder’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.87M Buy
49,400
+8,500
+21% +$462K 0.01% 682
2026
Q1
$2.38M Hold
40,900
0.01% 673
2025
Q4
$1.89M Sell
40,900
-4,100
-9% -$183K 0.01% 760
2025
Q3
$1.62M Buy
45,000
+10,100
+29% +$335K 0.01% 815
2025
Q2
$1.14M Hold
34,900
﹤0.01% 905
2025
Q1
$1.32M Buy
34,900
+3,400
+11% +$272K 0.01% 826
2024
Q4
$2.58M Buy
31,500
+4,400
+16% +$437K 0.01% 584
2024
Q3
$3.1M Sell
27,100
-200
-0.7% -$18K 0.01% 528
2024
Q2
$2.06M Buy
27,300
+7,700
+39% +$524K 0.01% 583
2024
Q1
$1.34M Hold
19,600
0.01% 727
2023
Q4
$1.23M Buy
19,600
+6,900
+54% +$358K 0.01% 714
2023
Q3
$647K Hold
12,700
﹤0.01% 930
2023
Q2
$634K Buy
12,700
+2,400
+23% +$114K ﹤0.01% 952
2023
Q1
$386K Hold
10,300
﹤0.01% 1140
2022
Q4
$494K Buy
+10,300
New +$404K ﹤0.01% 966

Other funds holding PCVX